FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Group Calls for Policy Changes to Sustain Generic, Biosimilar Competition

A new report from the Association for Accessible Medicines calls for changes to FDA policies, patent law, pharmacy benefit manager practices and feder...

latest-news-card-1
Human Drugs

Pharming Groups Joenja Gets Expanded Approval

FDA grants Pharming Group expanded approval for Joenja (leniolisib) tablets for treating activated phosphoinositide 3-kinase delta syndrome in childre...

latest-news-card-1
Human Drugs

Exelixis NDA Review Extended for Colorectal Cancer Drug

FDA extends by three months its review of an Exelixis NDA for zanzalintinib, in combination with atezolizumab, for treating patients with metastatic c...

latest-news-card-1
Human Drugs

FDA Oncology Chief to Focus on AI, Streamlined Drug Development

Oncology Center of Excellence director Angelo de Claro says the center will build on initiatives established under longtime and former OCE chief Richa...

latest-news-card-1
Human Drugs

Priority Review for Roche Enspryng sBLA

FDA grants a priority review for a Roche sBLA for Espryng to treat myelin oligodendrocyte glycoprotein antibody-associated disease, an autoimmune dise...

latest-news-card-1
Medical Devices

BMC Medical Recalls Sleep Apnea Machines

BMC Medical recalls its Luna G3 APAP (Model LG3600), an auto-adjusting positive airway pressure machine for treating obstructive sleep apnea, due to a...

latest-news-card-1
Human Drugs

FDA Partial Clinical Hold on Biohaven Epilepsy Drug

FDA issues a partial clinical hold on Biohavens opakalim (BHV-7000) due to nonclinical characterization of certain metabolites documented in rodent te...

latest-news-card-1
Human Drugs

3 Observations on XeCare FDA-483

FDA releases the Form FDA-483 with three observations from an inspection at New Albany, OH-based XeCare.

latest-news-card-1
Human Drugs

FDA Open to Alternative Approaches For Psychedelic Drug Trials

Writing in a in a New England Journal of Medicine article, FDA officials encourage novel approaches for developing psychedelic drugs for mental health...

latest-news-card-1
Human Drugs

Bill to Update FDA Drug Preclusion Rules

Rep. Diana Harshberger introduces legislation to aid the dietary supplement industry by changing FDAs drug preclusion rules.